Patents by Inventor Pieter A. Van Der Velden

Pieter A. Van Der Velden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230344342
    Abstract: An inductor-less power converter for converting an input voltage at an input terminal to an output voltage at an output terminal is provided, with a conversion ratio between the input and output voltage. The converter can be an inductor-less power converter which is configured for Direct Current, DC, to DC, DC-DC conversion of an input voltage to an output voltage. The input voltage is provided at an input terminal pair whereas the output voltage is provided at an output terminal pair. The ratio between the input voltage and the output voltage defines the conversion ratio, which may be either larger than one or smaller than one, meaning that the voltage may be stepped-up or stepped-down and thus increased or lowered.
    Type: Application
    Filed: April 20, 2023
    Publication date: October 26, 2023
    Applicant: NEXPERIA B.V.
    Inventor: Joram Pieter van der Velden
  • Publication number: 20230344270
    Abstract: The present disclosure relates to an energy harvesting system for converting a low-voltage input of an energy harvesting source into a Direct Current (DC) output voltage. The energy harvesting source is one of an energy harvesting source providing an Alternating Current (AC) output such as a piezoelectric energy harvesting source, and an energy harvesting source providing a DC output such as a photovoltaic energy harvesting source.
    Type: Application
    Filed: April 20, 2023
    Publication date: October 26, 2023
    Applicant: NEXPERIA B.V.
    Inventors: Joram Pieter van der Velden, Gustavo Campos Martins
  • Publication number: 20030175721
    Abstract: A method of determining predisposition to melanoma is provided in the form of a molecular diagnostic method that detects the presence of a cyclin dependent kinase inhibitor 2A mutant allele and/or a melanocortin-1 receptor variant allele. The presence of a cyclin dependent kinase inhibitor 2A mutant allele increases the probability that an individual carrying a melanocortin-1 receptor variant allele will develop melanoma. Similarly, the presence of a melanocortin-1 receptor variant allele increases the probability that an individual carrying a cyclin dependent kinase inhibitor 2A mutant allele will develop melanoma.
    Type: Application
    Filed: March 28, 2002
    Publication date: September 18, 2003
    Inventors: Neil F. Box, David L. Duffy, Nicholas K. Hayward, Nicholas G. Martin, Richard A. Sturm, Nelleke A. Gruis, Pieter A. Van Der Velden, Wilma Bergman, Rune R. Frants